Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listFosaprepitant dimeglumine

Fosaprepitant dimeglumine

  • CAS NO.:265121-04-8
  • Empirical Formula: C30H39F7N5O11P
  • Molecular Weight: 809.63
  • MDL number: MFCD23102059
  • EINECS: 682-419-4
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2024-11-08 21:13:59
Fosaprepitant dimeglumine Structural

What is Fosaprepitant dimeglumine?

Description

Fosaprepitant dimeglumine belongs to the group of antiemetics. The active substance inhibits part of the vomiting centre. It is used for the treatment of postoperative or chemotherapyinduced nausea and vomiting.

Chemical properties

Fosaprepitant dimeglumine is a white to off-white amorphous powder. It is freely soluble in water. The pH of a 1.0 g sample of fosaprepitant dimeglumine, dissolved in 25 mL of water, is approximately 8.3. Fosaprepitant, a prodrug of aprepitant, when administered intravenously is rapidly converted to aprepitant.

Originator

Merck (United States)

The Uses of Fosaprepitant dimeglumine

Fosaprepitant-d4 Dimeglumine is a labeled analogue of Fosaprepitant Dimeglumine (F727305), a selective neurokinin-1 (NK-1) receptor antahonist. Fosaprepitant is an antiemetic drug, a Aprepitant (A729800) prodrug.

The Uses of Fosaprepitant dimeglumine

Fosaprepitant is a water-soluble phosphoryl prodrug for Aprepitant which is a NK1 antagonist

Definition

ChEBI: Fosaprepitant dimeglumine is an organoammonium salt obtained by reaction of fosaprepitant with two equivalents of 1-deoxy-1-(methylamino)-D-glucitol. A substance P/neurokinin 1 (NK1) receptor antagonist. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors. Aprepitant has little or no affinity for serotonin (5-HT3), dopamine, and corticosteroid receptors, the targets of existing therapies for chemotherapy-induced nausea and vomiting and postoperative nausea and vomiting It has a role as a prodrug, an antiemetic and a neurokinin-1 receptor antagonist. It contains a fosaprepitant(2-).

Indications

Fosaprepitant dimeglumine is a new drug indicated to prevent nausea and vomiting associated with highly emetogenic cisplatin-based and moderately emetogenic cancer chemotherapy in adults.

brand name

IvEmend

Biological Activity

Fosaprepitant dimeglumine acts as a therapeutic agent to treat chemotherapy-induced nausea and vomiting. It also acts as a weak inhibitor of cytochrome P450 3A4 (CYP3A4).
Fosaprepitant dimeglumine is a Substance P/neurokinin-1 (NK1) receptor antagonist. It is a water soluble prodrug of the antiemetic drug aprepitant.
Fosaprepitant dimeglumine is a water-soluble prodrug form of the neurokinin-1 receptor antagonist aprepitant. Formulations containing fosaprepitant dimeglumine have been used to prevent chemotherapy-induced nausea and vomiting.

Side Effects

Most common adverse reactions in adults (≥2%) are: fatigue, diarrhea, neutropenia, asthenia, anemia, peripheral neuropathy, leukopenia, dyspepsia, urinary tract infection, pain in extremity.
Adverse reactions in pediatrics are similar to adults.

Mode of action

Fosaprepitant is a prodrug of aprepitant and accordingly, its antiemetic effects are attributable to aprepitant. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors.
Aprepitant has little or no affinity for serotonin (5-HT3), dopamine, and corticosteroid receptors, the targets of existing therapies for chemotherapy-induced nausea and vomiting (CINV). Aprepitant has been shown in animal models to inhibit emesis induced by cytotoxic chemotherapeutic agents, such as cisplatin, via central actions. Animal and human Positron Emission Tomography (PET) studies with aprepitant have shown that it crosses the blood brain barrier and occupies brain NK1 receptors. Animal and human studies have shown that aprepitant augments the antiemetic activity of the 5-HT3-receptor antagonist ondansetron and the corticosteroid dexamethasone and inhibits both the acute and delayed phases of cisplatin-induced emesis.

Clinical claims and research

One of the most debilitating side effects of cancer treatment is CINV. Although concomitant anti-emetic agents have been prevalent for the past two decades, 50 60% of patients are still plagued by CINV. To meet this need, fosaprepitant dimeglumine has been launched as a water-soluble, phosphoryl pro-drug of aprepitant for intravenous applications. This pro-drug is rapidly converted to aprepitant in vivo, which has a high affinity for the NK-1 receptor (IC50= 90 50 pM for the displacement of [125I]-substance P from hNK-1 expressed in CHO cells); antagonism 606 Shridhar Hegde and Michelle Schmidt of NK-1 prevents binding of the endogenous substance P that is known to induce vomiting. Fosaprepitant is prepared by the regioselective phosphorylation of aprepitant with dibenzylphosphoryl chloride followed by catalytic hydrogenolysis in the presence of N-methyl-Dglucamine. It is approved for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly and moderately emetogenic cancer chemotherapy.

References

[1] van belle sj1, cocquyt v. fosaprepitant dimeglumine (mk-0517 or l-785,298), an intravenous neurokinin-1 antagonist for the prevention of chemotherapy induced nausea and vomiting.expert opin pharmacother. 2008 dec; 9(18):3261-70.

Properties of Fosaprepitant dimeglumine

storage temp.  Sealed in dry,Store in freezer, under -20°C
solubility  ≥50.24 mg/mL in DMSO; insoluble in EtOH; ≥13.16 mg/mL in H2O with ultrasonic
form  Powder
pka Fosaprepitant dimeglumine has four functional groups which have pKa values of 3.05 ± 0.03, 4.92 ± 0.02, 9.67 ± 0.01 and 10.59 ± 0.03. The pka value of 3.05 corresponds to the morpholinium group, the pka of 4.92 corresponds to the monophosphonate group, the pka of 9.67 corresponds to the meglumine counter ion, and the pka of 10.59 corresponds to the triazolinone NH group.
color  White to off-white

Safety information for Fosaprepitant dimeglumine

Signal word Warning
Pictogram(s)
ghs
Exclamation Mark
Irritant
GHS07
GHS Hazard Statements H315:Skin corrosion/irritation
H319:Serious eye damage/eye irritation
Precautionary Statement Codes P280:Wear protective gloves/protective clothing/eye protection/face protection.
P302+P352:IF ON SKIN: wash with plenty of soap and water.
P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P332+P313:IF SKIN irritation occurs: Get medical advice/attention.
P337+P313:IF eye irritation persists: Get medical advice/attention.

Computed Descriptors for Fosaprepitant dimeglumine

Abamectin manufacturer

Piramal Pharma Solutions

1Y
Phone:+91-9892735994
Whatsapp: +91 9892735994
product: 265121-04-8 Fosaprepitant dimeglumine 99%
Inquiry

Aurobindo Pharma Limited

1Y
Phone:+914066725000
product: 265121-04-8 98%
Inquiry

Hetero Drugs Limited

1Y
Phone:+914023704923
product: Fosaprepitant dimeglumine 98%
Inquiry

Apothecon Pharmaceuticals Pvt Ltd

1Y
Phone:+91-9099007601
Whatsapp: +91-9099007601
product: Fosaprepitant dimeglumine 265121-04-8 99%
Inquiry

Moleculochem

1Y
Phone:+91-7972527229
Whatsapp: +91 9811853366
product: 265121-04-8 Fosaprepitant dimeglumine 98%
Inquiry

Rivashaa Agrotech Biopharma Pvt. Ltd.

1Y
Phone:+91-7926462688
product: 265121-04-8 98%
Inquiry

SMS Lifesciences India Ltd (MAHI Drugs Pvt Ltd)

1Y
Phone:+918374455507
Whatsapp: +91- 8374455507
product: Fosaprepitant dimeglumine 98%
Inquiry

Related products of tetrahydrofuran

You may like

  • 265121-04-8 Fosaprepitant dimeglumine 99%
    265121-04-8 Fosaprepitant dimeglumine 99%
    265121-04-8
    View Details
  • 265121-04-8 98%
    265121-04-8 98%
    265121-04-8
    View Details
  • 265121-04-8 Fosaprepitant dimeglumine 98%
    265121-04-8 Fosaprepitant dimeglumine 98%
    265121-04-8
    View Details
  • Fosaprepitant dimeglumine 98%
    Fosaprepitant dimeglumine 98%
    265121-04-8
    View Details
  • Fosaprepitant dimeglumine 265121-04-8 99%
    Fosaprepitant dimeglumine 265121-04-8 99%
    265121-04-8
    View Details
  • Fosaprepitant dimeglumine 98%
    Fosaprepitant dimeglumine 98%
    265121-04-8
    View Details
  • Fosaprepitant dimeglumine 98% (HPLC) CAS 265121-04-8
    Fosaprepitant dimeglumine 98% (HPLC) CAS 265121-04-8
    265121-04-8
    View Details
  • Fosaprepitant dimeglumine CAS 265121-04-8
    Fosaprepitant dimeglumine CAS 265121-04-8
    265121-04-8
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.